ABUS insider transaction filings
Arbutus Biopharma Corp — 18 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-10. Screen ABUS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Sawhney Roger — Director | Grant/award (A): 78,800 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Beardsley Robert A — Director | Grant/award (A): 78,800 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Nguyen Tuan — Chief Financial Officer | Grant/award (A): 73,500 @ $0 · Grant/award (A): 188,400 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Androski Lindsay — President and CEO, Director | Grant/award (A): 28,000 @ $0 · Grant/award (A): 71,700 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Sawhney Roger — Director | Grant/award (A): 157,600 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4/A | Nguyen Tuan — Chief Financial Officer | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | Nguyen Tuan — Chief Financial Officer | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Hasija Anuj — Director | Grant/award (A): 157,600 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Androski Lindsay — President and CEO, Director | Grant/award (A): 310,422 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Beardsley Robert A — Director | Grant/award (A): 157,600 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Naftzger J. Christopher — General Counsel and CCO | Grant/award (A): 54,300 @ $0 · Grant/award (A): 220,300 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | McElhaugh Michael J. — Interim President & CEO, Director | Grant/award (A): 177,000 @ $0 · Grant/award (A): 718,800 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Sims Karen — Chief Medical Officer | Grant/award (A): 49,300 @ $0 · Grant/award (A): 200,300 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | HASTINGS DAVID C — Chief Financial Officer | Grant/award (A): 90,100 @ $0 · Grant/award (A): 365,800 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | Sims Karen — Chief Medical Officer | Sale (S): 19,348 @ $3.28 | EDGAR |
| 2025-02-05 | 4 | McElhaugh Michael J. — Interim President & CEO, Director | Sale (S): 23,790 @ $3.28 | EDGAR |
| 2025-02-05 | 4 | Naftzger J. Christopher — General Counsel and CCO | Sale (S): 11,333 @ $3.28 | EDGAR |
| 2025-02-05 | 4 | HASTINGS DAVID C — Chief Financial Officer | Sale (S): 22,183 @ $3.28 | EDGAR |
Recent 8-K events — Arbutus Biopharma Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ABUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →